Ravi Viswanathan, 10% Owner at AVEO PHARMACEUTICALS INC (AVEO), bought 1,327,432 shares at $2.26 ($3.0M) on 2018-08-21, disclosed to the SEC on 2018-08-22.
Open-market purchase of $3.0M AVEO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.26 | 663,716 | $1.5M | 50.0% |
| 2 | $2.26 | 663,716 | $1.5M | 50.0% |
| Total | $2.26 avg | 1,327,432 | $3.0M | 100% |
| Filing → |
| AVEO | BUY | 2018-06-28 | $404K | — | Filing → |
| AVEO | BUY | 2018-05-30 | $591 | — | Filing → |
| AVEO | BUY | 2018-05-21 | $897K | — | Filing → |